Molecular Quality Controls Market is expected to generate a revenue of USD 240.87 Million by 2028, Globally, at 7.27% CAGR: Verified Market Research®

The primary reasons propelling the global Molecular Quality Controls Market are the increasing number of licensed medical laboratories, the expansion of third-party quality controls, and the growing inclination for external quality assessment support.

JERSEY CITY, N.J., Sept. 16, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Molecular Quality Controls Market" By Product (Instrument-Specific Controls, Independent Controls), By Analyte Type (Single-Analyte Controls, Multi-Analyte Controls), By Application (Infectious Diseases, Genetic Testing), By End-User (Clinical Laboratories, Hospitals), and By Geography.

According to the extensive research done by Verified Market Research experts, the market was valued at USD 147.2 Million in 2020 and is projected to reach USD 240.87 Million by 2028, growing at a CAGR of 7.27% from 2021 to 2028.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=7672

Browse in-depth TOC on "Molecular Quality Controls Market"

202 - Pages
126 – Tables
37 – Figures

Key Developments

• In June 2021, SeraCare collaborated with the International Quality Network for Pathology to develop, manufacture, and deliver a range of highly characterized cell line genomic DNA and formalin-fixed, paraffin-embedded standards with substantiated low, mid, and high levels of mutational burden within their exome regions.
• In May 2021, Bio-Rad has entered into a global partnership with Roche Diagnostics to provide its customers with a full line of InteliQ products and Unity QC data management solutions, as also customer training and equipment services.

Global Molecular Quality Controls Market Overview

Molecular quality controls can be used to assess the efficacy of in vitro nucleic acid testing processes for viral load tests, universal health care illnesses, and infections caused by sexually transmitted diseases. The primary goal of these quality controls is to evaluate molecular diagnostic products for faults and to notify management authorities. This determines the decision to reveal the product or not.

The increasing number of licensed clinical laboratories, increased usage of third-party quality controls, and a growing preference for external quality assessment help are the primary factors driving the global Molecular Quality Controls Market. The number of laboratory tests performed has increased as the prevalence of various diseases around the world has increased. Both the public and private sectors are increasing the number of laboratories to meet this requirement. Clinical laboratories in most countries are accredited by regulatory authorities such as the International Organization for Standardization and other similar standards to perform diagnostic tests. The appropriate authorities assess a laboratory's competency and quality system in comparison to predetermined standards during the accreditation procedure. Additionally, the creation of molecular diagnostic tools for the detection of cancer and infectious disorders. Increases in the number of accredited clinical laboratories, the adoption of third-party quality controls by end users, and the demand for external quality assessment support all contributed to the market's expansion.

Key Players

The major players in the market are Maine Molecular Quality Controls, Seracare Life Sciences, Inc., Roche Diagnostics, Zeptometrix, Thermo Fisher Scientific, Abbott Laboratories, Theranostica, Bio-Rad Laboratories, Microbiologics, Inc., Qnostics, Grena Think Medical, and Quidel.

Verified Market Research has segmented the Global Molecular Quality Controls Market On the basis of Product, Analyte Type, Application, End-User, and Geography.

• Molecular Quality Controls Market, By Product
• Instrument-Specific Controls
• Independent Controls
• Molecular Quality Controls Market, By Analyte Type
• Single-Analyte Controls
• Multi-Analyte Controls
• Molecular Quality Controls Market, By Application
• Infectious Diseases
• Genetic Testing
• Oncology
• Other Applications
• Molecular Quality Controls Market, By End-User
• Academic & Research Institutes
• Clinical Laboratories
• IVD manufacturers and Contract Research Organizations
• Hospitals
• Other
• Molecular Quality Controls Market, by Geography
• North America
• U.S
• Canada
• Mexico
• Europe
• Germany
• France
• U.K
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• ROW
• Middle East & Africa
• Latin America

Browse Related Reports:

Non-Therapeutic Biomolecules Market By End User (Research, Pharma and IVD), By IVD Moleculaire (Oligonucleotides, Plasmids and Enzymes), By IVD IA (Recombinant Proteins, Plasmids, Enzymes), By Pharma ATM (Recombinant Proteins and Plasmids), By Trad Pharma (Enzymes, Recombinant Proteins), By Pharma CRO (Enzymes, Recombinant Proteins), By Trad Pharma (Enzymes, Recombinant Proteins, Plasmids), By Geography, And Forecast

RSV Diagnostics Market By Method (Rapid Antigen Detection Tests, Molecular Diagnostics), By Product (Kits and Assays, Instruments), By Geography, And Forecast

Pharmacokinetics Services Market By Type (Small Molecules Services, Large Molecules Services), By Application (Small and Medium Enterprise, Large Enterprise), By Geographic Scope And Forecast, By Geography, And Forecast

In Vitro Diagnostics (IVD) Quality Control Product Market By Product (Quality Control Products, Quality Assurance Services), By Application (Clinical Chemistry, Immunochemistry, Hematology, Molecular Diagnostics, Others) By Geography, And Forecast

Top 10 Point-Of-Care Molecular Diagnostics Companies supplying improved testing methods

Visualize Molecular Quality Controls Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research®
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1315349/Verified_Market_Research_Logo.jpg